Program for older adults with cognitive impairment living alone
Home Alone: Developing a Home-Based Intervention for People With Cognitive Impairment Who Live Alone
This study is testing a program that helps older adults with memory issues who live alone by providing weekly meetings with a coach to see if it can improve their safety and social well-being at home.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 65 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT05746390 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the 'Home Alone' program designed for older adults with cognitive impairment who live alone. The program aims to enhance engagement and safety at home through a series of weekly meetings with a coach and surveys over a period of three to six months. The study will assess the feasibility, acceptability, and effectiveness of this intervention, adapting established mental health and dementia care models to meet the needs of participants. The goal is to improve social well-being and maintain cognitive function for those living independently.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 55 and older who live alone and have a diagnosis of mild cognitive impairment or similar cognitive challenges.
Not a fit: Patients living in assisted care facilities or those currently receiving similar psychosocial services may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and cognitive function for older adults living alone with cognitive impairment.
How similar studies have performed: Other studies have shown promise in using tailored interventions for cognitive impairment, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 55 years of age or older * Lives alone in a non-residential setting * Either 1) provider diagnosis of MCI, 2) Montreal Cognitive Assessment by telephone (T-MoCA) score between 13 and 18, and/or 3) subjective endorsement of memory impairment on screening * Resides in the US * Demonstrates capacity to consent Exclusion Criteria: Those who do not meet the inclusion criteria above are not eligible. Additionally, researchers would exclude those who: * Live in assisted living, a group care home, or similar residential setting that provides care and services * Are not English speaking * Are currently participating in any other type of service that provides one-to-one psychosocial consultation or independent living coaching * Have a new or worsening mental health condition and are not receiving ongoing treatment * Have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics, or anti-psychotics, for the prior three months * Are not willing/interested in participating or cannot actively participate in the intervention, per researcher discretion
Where this trial is running
Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Joseph Gaugler, PhD — University of Minnesota
- Study coordinator: Joseph Gaugler, PhD
- Email: gaug0015@umn.edu
- Phone: 612-626-2485
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.